The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Regulation of Bone Remodeling by Parathyroid Hormone
Open accessAbstract
Parathyroid hormone (PTH) exerts profound effects on skeletal homeostasis through multiple cellular and molecular mechanisms.Continuous hyperparathyroidism causes net loss of bone mass, despite accelerating bone formation by osteoblasts.Intermittent treatment with PTH analogs represents the only Food and Drug Administration (FDA)-approved bone anabolic osteoporosis treatment strategy.Functional PTH receptors are present on cells of the osteoblast lineage, ranging from early skeletal stem cells to matrix-embedded osteocytes.In addition, bone remodeling by osteoclasts liberates latent growth factors present within bone matrix.Here, we will provide an overview of the multiple cellular and molecular mechanisms through which PTH influences bone homeostasis.Notably, net skeletal effects of continuous versus intermittent can differ significantly.Where possible, we will highlight mechanisms through which continuous hyperparathyroidism leads to bone loss, and through which intermittent hyperparathyroidism boosts bone mass.Given the therapeutic usage of intermittent PTH (iPTH) treatment for osteoporosis, particular attention will be paid toward mechanisms underlying the bone anabolic effects of once daily PTH administration.P arathyroid hormone (PTH) is a major endocrine regulator of extracellular calcium and phosphate levels (Gensure et al. 2005).Chronic hyperparathyroidism causes net loss of bone mass caused by excessive stimulation of bone resorption, but also increases osteoblast numbers and bone formation.In contrast, when injected once daily, intermittent PTH (iPTH) amino acids 1-34 (teriparatide) treatment boosts bone mass, increases bone formation, and reduces fractures in at-risk individuals (Silva et al. 2011).PTH and parathyroid hormone related peptide (PTHrP) both signal through the same G protein-coupled receptor (Juppner et al. 1991).Recently, the PTHrP analog, abaloparatide, has
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80257-3 · Cited by 4,246
Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287
WNT signaling in bone homeostasis and disease: From human mutations to treatments
Baron, R., & Kneissel, M. (2013) · Nature Medicine · doi:10.1038/nm.3074 · Cited by 2,093
Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061775 · Cited by 1,554
Regulation of bone mass by Wnt signaling
Krishnan, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28551 · Cited by 1,407
Zhou, B. O., Yue, R., Murphy, M. M., Peyer, J. G., & Morrison, S. J. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.06.008 · Cited by 1,381 · cited 1×
“A different pattern of expression was revealed through the use the leptin receptor-Cre transgene to mark mesenchymal cells in bone (Zhou et al. 2014).”
BackgroundMechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin
Robling, A. G., Niziolek, P. J., Baldridge, L. A., Condon, K. W., Allen, M. R., Alam, I., Mantila, S. M., Gluhak-Heinrich, J., Bellido, T. M., Harris, S. E., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705092200 · Cited by 1,350
Leptin regulation of bone resorption by the sympathetic nervous system and CART
Elefteriou, F., Ahn, J. D., Takeda, S., Starbuck, M., Yang, X., Liu, X., Kondo, H., Richards, W. G., Bannon, T. W., Noda, M., et al. (2005) · Nature · doi:10.1038/nature03398 · Cited by 1,311 · cited 1×
“Although both of these inputs induce RANKL in a cAMP-dependent manner in osteoblastic cells, SNS-induced RANKL up-regulation requires ATF4, whereas PTH-induced RANKL does not (Elefteriou et al. 2005).”
BackgroundMatrix-embedded cells control osteoclast formation
Xiong, J., Onal, M., Jilka, R. L., Weinstein, R. S., Manolagas, S. C., & O'Brien, C. A. (2011) · Nature Medicine · doi:10.1038/nm.2448 · Cited by 1,304
Kato, M., Patel, M. S., Levasseur, R., Lobov, I., Chang, B. H.-J., Glass, D. A., Hartmann, C., Li, L., Hwang, T.-H., Brayton, C. F., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200201089 · Cited by 1,086 · cited 1×
“In preosteoblasts, canonicalWNT signaling stimulates replication and promotes osteoblast differentiation (Kato et al. 2002).”
Background
Cited by
Advances in pathogenesis and therapeutic strategies for osteoporosis
Song, S., Guo, Y., Yang, Y., & Fu, D. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108168 · Cited by 476
Wu, Y., Xie, L., Wang, M., Xiong, Q., Guo, Y., Liang, Y., Li, J., Sheng, R., Deng, P., Wang, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06898-4 · Cited by 430
Current Status of the Diagnosis and Management of Osteoporosis
Aibar-Almazán, A., Voltes-Martínez, A., Castellote-Caballero, Y., Afanador-Restrepo, D. F., Carcelén-Fraile, M. D. C., & López-Ruiz, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169465 · Cited by 412
Modulation of bone remodeling by the gut microbiota: A new therapy for osteoporosis
Lyu, Z., Hu, Y., Guo, Y., & Liu, D. (2023) · Bone Research · doi:10.1038/s41413-023-00264-x · Cited by 207
Parathyroid hormone-dependent bone formation requires butyrate production by intestinal microbiota
Li, J.-Y., Yu, M., Pal, S., Tyagi, A. M., Dar, H., Adams, J., Weitzmann, M. N., Jones, R. M., & Pacifici, R. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133473 · Cited by 198
PTH induces bone loss via microbial-dependent expansion of intestinal TNF+ T cells and Th17 cells
Yu, M., Malik Tyagi, A., Li, J.-Y., Adams, J., Denning, T. L., Weitzmann, M. N., Jones, R. M., & Pacifici, R. (2020) · Nature Communications · doi:10.1038/s41467-019-14148-4 · Cited by 148
Targeting WNT signaling in the treatment of osteoporosis
Baron, R., & Gori, F. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.04.011 · Cited by 101
Regulation of Energy Metabolism by Bone-Derived Hormones
Mera, P., Ferron, M., & Mosialou, I. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031666 · Cited by 90
Turner, M. E., Beck, L., Hill Gallant, K. M., Chen, Y., Moe, O. W., Kuro-o, M., Moe, S. M., & Aikawa, E. (2024) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.123.319198 · Cited by 54
A review of mathematical modeling of bone remodeling from a systems biology perspective
Cook, C. V., Lighty, A. M., Smith, B. J., & Ford Versypt, A. N. (2024) · Frontiers in Systems Biology · doi:10.3389/fsysb.2024.1368555 · Cited by 25
miR-433-3p suppresses bone formation and mRNAs critical for osteoblast function in mice
Garcia, J., Smith, S. S., Karki, S., Drissi, H., Hrdlicka, H. H., Youngstrom, D. W., & Delany, A. M. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4339 · Cited by 16
Metadata
- Authors
- Wein, M. N., & Kronenberg, H. M.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2018-01-22
- Volume
- 8
- Issue
- 8
- Pages
- a031237
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2784497332
- Cited by
- 241
- References
- 32
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.